Efficacy of social cognition and interaction training in outpatients with schizophrenia spectrum disorders
Randomized controlled trial
Bibliographic Data
| ID | 15520932 |
|---|---|
| Authors | Joanna M Fiszdon (Yale University, corresponding author), H Drew Dixon (0009-0006-8730-6986, Mercer University), Charlie A Davidson (0000-0002-2222-6428, Emory University), David L Roberts (0000-0001-6788-2691, The University of Texas at San Antonio Health Science Center), David L Penn (0000-0003-4567-0166, University of North Carolina at Chapel Hill), Morris D Bell (0000-0003-0795-9196, Yale University) |
| Year | 2023 |
| Volume | 14 |
| Pages | 1217735-1217735 |
| Publication date | 2023-08-04 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1217735 |
| PMID | 37599886 |
| OpenAlex | W4385892459 |
| Language | EN |
| Citations received | 1 |
| References cited | 9 |
Given the relationship between social cognition and functional outcome in schizophrenia, a number of social cognitive interventions have been developed, including Social Cognition Interaction Training (SCIT), a group-based, comprehensive, manualized intervention. In the current trial, we examined SCIT efficacy as well as potential moderators of treatment effects. Fifty-one outpatients were randomized to SCIT or a wait-list-control (WLC), with assessments of social cognition, neurocognition, self-report, symptoms, and functioning conducted at baseline and end of the active phase. Relative to WLC, we did not find significant improvements for SCIT on neurocognition, social cognition, self-report, or symptoms, though there was a trend-level, medium effect favoring the SCIT condition on interpersonal and instrumental role function. Post-hoc analyses indicated that baseline neurocognition did not impact degree of social cognitive or functional change. Shorter duration of illness was significantly associated with better post-training neurocognition and self-esteem and, at trend-level with better symptoms and social functioning. We discuss the importance of outcome measure selection and the need for continued evaluation of potential treatment moderators in order to better match people to existing treatments. Clinical trial registration : Clinicaltrials.gov, Identifier NCT00587561
Cognition · Developmental psychology · Neurocognitive · Psychiatry · Psychological intervention · Randomized controlled trial · Schizophrenia (object-oriented programming · Social cognition · Social cognitive theory · Social skills · Child and Adolescent Psychosocial and Emotional Development · Clinical Psychology · Medicine · Mental Health Research Topics · Psychology · Schizophrenia research and treatment · Internal Medicine
The Social Functioning Scale the Development and Validation of a New Scale of Social Adjustment for use in Family Intervention Programmes with Schizophrenic Patients
The Quality of Life Scale
Measurement of social-evaluative anxiety.
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
The Feasibility and Efficacy of Social Cognition and Interaction Training for Outpatients With Schizophrenia in Japan
Virtual-reality-based social cognition and interaction training for patients with schizophrenia
A randomized controlled trial of social cognition and interaction training for persons with first episode psychosis in Hong Kong
Randomized Controlled Trial of Adjunctive Social Cognition and Interaction Training, Adjunctive Therapeutic Alliance Focused Therapy, and Treatment As Usual Among Persons With Serious Mental Illness
Does Adding Social Cognitive Remediation Therapy to Neurocognitive Remediation Therapy Improve Outcomes in Young People With a Severe Mental Illness?—The Advantage Trial
| Citations per year | 1 |
|---|---|
| Citation span | 2026 - 2026 (1) |
| Highly cited | No |